Insider Transactions in Q1 2023 at Adma Biologics, Inc. (ADMA)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,853
-0.7%
|
$53,559
$3.31 P/Share
|
Mar 31
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,469
-1.51%
|
$46,407
$3.31 P/Share
|
Mar 07
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,965
-1.63%
|
$50,895
$3.4 P/Share
|
Mar 07
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,607
-0.91%
|
$70,821
$3.4 P/Share
|
Mar 06
2023
|
Bryant Fong |
BUY
Grant, award, or other acquisition
|
Direct |
25,815
+30.12%
|
-
|
Mar 06
2023
|
Young Kwon |
BUY
Grant, award, or other acquisition
|
Direct |
25,815
+9.28%
|
-
|
Mar 06
2023
|
Martha J Demski |
BUY
Grant, award, or other acquisition
|
Indirect |
25,815
+31.32%
|
-
|
Mar 06
2023
|
Lawrence P. Guiheen |
BUY
Grant, award, or other acquisition
|
Direct |
25,815
+16.58%
|
-
|
Mar 06
2023
|
Steve Elms |
BUY
Grant, award, or other acquisition
|
Direct |
25,815
+33.0%
|
-
|
Mar 06
2023
|
Jerrold B Grossman |
BUY
Grant, award, or other acquisition
|
Direct |
25,815
+7.61%
|
-
|
Mar 06
2023
|
Brian Lenz EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
135,175
+11.49%
|
-
|
Mar 06
2023
|
Adam S Grossman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
573,695
+18.16%
|
-
|
Feb 28
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,000
-0.55%
|
$15,000
$3.55 P/Share
|
Feb 28
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,507
-0.37%
|
$22,521
$3.55 P/Share
|
Feb 25
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,486
-0.52%
|
$28,458
$3.42 P/Share
|
Feb 25
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,430
-0.45%
|
$55,290
$3.42 P/Share
|
Jan 04
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
114,222
-11.04%
|
$342,666
$3.87 P/Share
|
Jan 04
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
166,867
-7.57%
|
$500,601
$3.87 P/Share
|